» Articles » PMID: 35777761

Bone Morphogenetic Protein 4 Inhibits Pulmonary Fibrosis by Modulating Cellular Senescence and Mitophagy in Lung Fibroblasts

Abstract

Background: Accumulation of myofibroblasts is critical to fibrogenesis in idiopathic pulmonary fibrosis (IPF). Senescence and insufficient mitophagy in fibroblasts contribute to their differentiation into myofibroblasts, thereby promoting the development of lung fibrosis. Bone morphogenetic protein 4 (BMP4), a multifunctional growth factor, is essential for the early stage of lung development; however, the role of BMP4 in modulating lung fibrosis remains unknown.

Methods: The aim of this study was to evaluate the role of BMP4 in lung fibrosis using BMP4-haplodeleted mice, BMP4-overexpressed mice, primary lung fibroblasts and lung samples from patients with IPF.

Results: BMP4 expression was downregulated in IPF lungs and fibroblasts compared to control individuals, negatively correlated with fibrotic genes, and BMP4 decreased with transforming growth factor (TGF)-β1 stimulation in lung fibroblasts in a time- and dose-dependent manner. In mice challenged with bleomycin, BMP4 haploinsufficiency perpetuated activation of lung myofibroblasts and caused accelerated lung function decline, severe fibrosis and mortality. BMP4 overexpression using adeno-associated virus 9 vectors showed preventative and therapeutic efficacy against lung fibrosis. , BMP4 attenuated TGF-β1-induced fibroblast-to-myofibroblast differentiation and extracellular matrix (ECM) production by reducing impaired mitophagy and cellular senescence in lung fibroblasts. Pink1 silencing by short-hairpin RNA transfection abolished the ability of BMP4 to reverse the TGF-β1-induced myofibroblast differentiation and ECM production, indicating dependence on Pink1-mediated mitophagy. Moreover, the inhibitory effect of BMP4 on fibroblast activation and differentiation was accompanied with an activation of Smad1/5/9 signalling and suppression of TGF-β1-mediated Smad2/3 signalling and .

Conclusion: Strategies for enhancing BMP4 signalling may represent an effective treatment for pulmonary fibrosis.

Citing Articles

Integrative analysis of gene expression and chromatin dynamics multi-omics data in mouse models of bleomycin-induced lung fibrosis.

Li Z, Zhang M, Zhang Y, Gan Y, Zhu Z, Wang J Epigenetics Chromatin. 2025; 18(1):11.

PMID: 40069909 PMC: 11900494. DOI: 10.1186/s13072-025-00579-5.


circ0066187 promotes pulmonary fibrogenesis through targeting STAT3-mediated metabolism signal pathway.

Liu B, Liu W, Li H, Zhai N, Lv C, Song X Cell Mol Life Sci. 2025; 82(1):79.

PMID: 39969586 PMC: 11839971. DOI: 10.1007/s00018-025-05613-z.


Update of Aging Hallmarks in Idiopathic Pulmonary Fibrosis.

Torres-Machorro A, Garcia-Vicente A, Espina-Ordonez M, Luis-Garcia E, Negreros M, Herrera I Cells. 2025; 14(3).

PMID: 39937013 PMC: 11817138. DOI: 10.3390/cells14030222.


GATA2 participates in protection against hypoxia-induced pulmonary vascular remodeling.

Shirota Y, Ohmori S, Engel J, Moriguchi T PLoS One. 2024; 19(12):e0315446.

PMID: 39739870 PMC: 11687799. DOI: 10.1371/journal.pone.0315446.


Targeting Fibrosis: From Molecular Mechanisms to Advanced Therapies.

Di X, Li Y, Wei J, Li T, Liao B Adv Sci (Weinh). 2024; 12(3):e2410416.

PMID: 39665319 PMC: 11744640. DOI: 10.1002/advs.202410416.


References
1.
Farkas L, Farkas D, Gauldie J, Warburton D, Shi W, Kolb M . Transient overexpression of Gremlin results in epithelial activation and reversible fibrosis in rat lungs. Am J Respir Cell Mol Biol. 2010; 44(6):870-8. PMC: 3135847. DOI: 10.1165/rcmb.2010-0070OC. View

2.
Rafii R, Juarez M, Albertson T, Chan A . A review of current and novel therapies for idiopathic pulmonary fibrosis. J Thorac Dis. 2013; 5(1):48-73. PMC: 3548009. DOI: 10.3978/j.issn.2072-1439.2012.12.07. View

3.
Jiang Q, Liu C, Liu S, Lu W, Li Y, Luo X . Dysregulation of BMP9/BMPR2/SMAD signalling pathway contributes to pulmonary fibrosis and pulmonary hypertension induced by bleomycin in rats. Br J Pharmacol. 2020; 178(1):203-216. DOI: 10.1111/bph.15285. View

4.
Kuwano K, Kunitake R, Kawasaki M, Nomoto Y, Hagimoto N, Nakanishi Y . P21Waf1/Cip1/Sdi1 and p53 expression in association with DNA strand breaks in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 1996; 154(2 Pt 1):477-83. DOI: 10.1164/ajrccm.154.2.8756825. View

5.
Zhao H, Bian H, Bu X, Zhang S, Zhang P, Yu J . Targeting of Discoidin Domain Receptor 2 (DDR2) Prevents Myofibroblast Activation and Neovessel Formation During Pulmonary Fibrosis. Mol Ther. 2016; 24(10):1734-1744. PMC: 5112036. DOI: 10.1038/mt.2016.109. View